STOCKSCREENR

EMBC

NASDAQ

Embecta Corp.

$9.23+0.08(+0.87%)Mkt Cap: $546.60M

Key Stats

Market Cap

$546.60M

P/E Ratio

3.91

EPS

$2.36

Dividend Yield

6.31%

52-Week Range

$8.47 — $15.55

Volume

727.47K

Avg Volume

875.63K

Beta

1.10

Price Alerts for EMBC

Get alerted when EMBC hits your target price.

$

Free — enter your email to get started

Valuation

P/E (TTM)

3.91

Forward P/E

3.28

PEG Ratio

0.08

P/S (TTM)

0.52

P/B (TTM)

-0.90

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

-0.21%

ROA (TTM)

0.13%

ROIC

—

Gross Margin

0.64%

Operating Margin

0.32%

Net Margin

—

Debt/Equity

-2.32

Current Ratio

2.64

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

-0.12%

EPS Growth (5Y)

-0.17%

Sales Growth (3Y)

-0.01%

Sales Growth (5Y)

-0.00%

EPS Est (This Year)

$2.81

EPS Est (Next Year)

$2.88

Dividends

Dividend Yield

—

Annual Dividend

$0.15

Payout Ratio

—

Frequency

—

Ex-Dividend Date

2025-12-05

Cash/Share

$3.51

Analyst Consensus

Price Target Range

$20.00$22.50$25.00
LowMedianHigh

Consensus Target: $22.50(143.8% upside)

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

—

Outstanding Shares

59.22M

Float

58.32M

Free Float %

98.48%

Technicals

RSI (14)

29.81

SMA 20

$11.15

SMA 50

$11.65

SMA 200

$12.38

ATR (14)

0.77

Volatility (Week)

0.05%

Volatility (Month)

0.03%

Pattern

Hammer

Performance

1 Day

-0.97%

1 Week

-10.22%

1 Month

-20.70%

3 Months

-25.46%

6 Months

-23.50%

1 Year

—

YTD

-12.61%

All-Time High

$18.06

About

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Country

US

Exchange

NASDAQ

IPO Date

2022-03-22

Employees

2000

CEO

Devdatt Kurdikar

Index Membership

—

Website

https://www.embecta.com

Embecta Corp. (EMBC) is a healthcare company in the drug manufacturers - specialty & generic industry listed on the NASDAQ. With a market capitalization of $546.60M, a P/E ratio of 3.91, and a dividend yield of 6.31%, EMBC is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare EMBC against other stocks using dozens of fundamental and technical filters.

Similar Stocks

TLRY

Tilray Brands, Inc.

$6.16

-1.28%

$736.76M

AMPH

Amphastar Pharmaceuticals, Inc.

$21.88

-0.36%

$974.43M

EOLS

Evolus, Inc.

$5.33

-1.11%

$346.77M

LOVE.V

Cannara Biotech Inc.

$1.89

+6.18%

$181.03M

ORGO

Organogenesis Holdings Inc.

$2.57

+9.36%

$330.61M

HCM

HUTCHMED (China) Limited

$13.30

-1.04%

$2.32B

Frequently Asked Questions

What is Embecta Corp.'s P/E ratio?

Embecta Corp. (EMBC) has a trailing twelve-month (TTM) P/E ratio of 3.91. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Embecta Corp. pay a dividend?

No, Embecta Corp. (EMBC) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Embecta Corp.'s market cap?

Embecta Corp. (EMBC) has a market capitalization of $546.60 million, classifying it as a small-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.

How has EMBC performed this year?

Embecta Corp. (EMBC) has returned -12.61% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.